Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TechnipFMC plc Ordinary Share (FTI) vs Medpace Holdings Inc (MEDP) Price & Performance

TechnipFMC plc Ordinary ShareTrade
Medpace Holdings IncTrade

Price performance (Past 24H)

Key statistics

TechnipFMC plc Ordinary Share vs Medpace Holdings Inc — how do they compare? TechnipFMC plc Ordinary Share trades at $69.57 (market cap $27.31B), while Medpace Holdings Inc trades at $612.05 (market cap $16.82B). The key difference: TechnipFMC plc Ordinary Share is the larger of the two by market cap, and TechnipFMC plc Ordinary Share pays a 0.29% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TechnipFMC plc Ordinary Share for 1 Days and Medpace Holdings Inc for 14 Days on average.

FTIMEDP
Market Cap
$27.31B$16.82B
Volume
2,496,410223,093
Sector
EnergyHealth
52-Week High
$80.08$630.19
52-Week Low
$35.57$393.42
Typical Hold Time
1 Days14 Days
Enterprise Value
$27.56B$16.44B
Dividend Yield
0.29%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TechnipFMC plc Ordinary Share

No Aura AI signal available yet.

Medpace Holdings Inc

Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.

MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FTI

No sentiment data available yet.

MEDP
100% Buy0% Sell
Avg holding period · 14 Days

About TechnipFMC plc Ordinary Share

TechnipFMC is an energy technology company providing subsea systems, surface technologies, and related services across the life of oil and gas fields. Its offerings include equipment, controls, installation support, and digital tools for offshore and onshore projects.

Read more on FTI →

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP →